| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.39B | 11.30B | 11.21B | 10.21B | 8.63B |
| Gross Profit | 4.85B | 4.39B | 4.38B | 4.04B | 3.37B |
| EBITDA | 1.85B | 1.85B | 1.94B | 1.88B | 1.57B |
| Net Income | 1.15B | 1.20B | 1.29B | 1.24B | 985.84M |
Balance Sheet | |||||
| Total Assets | 7.00B | 6.00B | 5.71B | 5.37B | 4.76B |
| Cash, Cash Equivalents and Short-Term Investments | 494.24M | 703.20M | 766.59M | 737.88M | 431.56M |
| Total Debt | 2.18B | 1.92B | 1.91B | 1.90B | 1.85B |
| Total Liabilities | 4.20B | 3.51B | 3.43B | 3.41B | 3.23B |
| Stockholders Equity | 2.80B | 2.49B | 2.28B | 1.96B | 1.54B |
Cash Flow | |||||
| Free Cash Flow | 1.07B | 964.15M | 1.04B | 1.17B | 887.08M |
| Operating Cash Flow | 1.50B | 1.34B | 1.48B | 1.48B | 1.06B |
| Investing Cash Flow | -931.35M | -383.09M | -441.43M | -314.58M | -176.48M |
| Financing Cash Flow | -850.67M | -1.02B | -1.01B | -861.01M | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $1.37B | 7.65 | 23.43% | ― | -0.42% | 31.64% | |
63 Neutral | $23.10B | 25.17 | 44.07% | ― | 5.45% | 4.28% | |
63 Neutral | $41.94B | 19.34 | 42.68% | 1.38% | 4.89% | 17.30% | |
63 Neutral | $10.47B | 57.58 | 55.17% | ― | 9.80% | -46.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | $4.08B | 7.11 | -44.22% | 4.16% | -1.04% | -20.88% | |
55 Neutral | $5.29B | 33.41 | -15.36% | ― | 1.98% | -20.98% |
On December 15, 2025, Ulta Beauty, Inc. adopted a new Executive Severance Plan that standardizes severance and benefits for its executive officers in the event of an involuntary termination without cause, excluding terminations tied to a change in control, death, or disability. Under the plan, eligible executives will receive two times base salary paid over 24 months, a cash lump sum equal to one times the lower of their target or actual annual bonus for the year of termination, and up to 12 months of company-paid COBRA premiums, contingent on signing a release of claims and complying with restrictive covenants for 24 months; the plan replaces prior severance arrangements for executives but leaves intact the company’s existing change-in-control severance framework, signaling a move toward more unified and predictable executive exit terms for stakeholders.
The most recent analyst rating on (ULTA) stock is a Buy with a $700.00 price target. To see the full list of analyst forecasts on Ulta Beauty stock, see the ULTA Stock Forecast page.